Public Interest in Myocarditis during the SARS-CoV-2 Pandemic

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Objective: Public interest in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines has been rising with regard to associated myocarditis. Thus, the objective of our study was to assess trends in public interest in myocarditis during the course of the pandemic and the SARS-CoV-2 vaccine rollout in the United States.

Methods: We conducted a longitudinal assessment of public interest in myocarditis, and its association with actual coronavirus disease 2019 (COVID-19) -related myocarditis during the first wave of the pandemic and SARS-CoV-2 vaccine-related myocarditis following vaccine rollout. To complete this objective, we used data from 3 sources: a report from the Morbidity and Mortality Weekly Report, the Vaccine Adverse Event Reporting database, and from Google Trends.

Results: Results show that Relative Search Interest (RSI) was low before and during the initial phase of the pandemic and peaked in April 2021, during the initial vaccine push. The ratio of myocarditis related to the SARS-CoV-2 vaccines was considerably lower than the ratio of myocarditis from natural infection.

Conclusions: Search interest in myocarditis was low until SARS-CoV-2 vaccines were rolled out, in which media coverage intensely focused on a relatively small number of cases. This study highlights both the benefits of COVID-19 vaccine uptake and the impact of the media on public interest
Original languageAmerican English
Pages (from-to)e349
JournalDisaster medicine and public health preparedness
StatePublished - 13 Mar 2023


  • Myocarditis
  • COVID-19
  • SARS-CoV-2
  • vaccines
  • public interest


Dive into the research topics of 'Public Interest in Myocarditis during the SARS-CoV-2 Pandemic'. Together they form a unique fingerprint.

Cite this